Archived Newsletters

11. 06.09.25 -- To Enhance Biotech Investments, Involve CDMOs Early In CMC Decisions 6/9/2025
    06/09/25 Outsourced Pharma Newsletter
12. 06.06.25 -- Inside the Minds Transforming Medicine — Must-Hear Podcasts on RNAi, tRNA, AI & More 6/6/2025
    06/06/25 Outsourced Pharma Newsletter
13. 06.06.25 -- A Psychedelic Path To CDMO Selection? 6/6/2025
    06/06/25 Outsourced Pharma Newsletter
14. 06.05.25 -- Master The Final Critical Step In Drug Manufacturing 6/5/2025

    06/05/25 Outsourced Pharma Newsletter

15. 06.05.25 -- Driving Patient-Centric Innovation In Pediatric Drug Development And Delivery 6/5/2025

    06/05/25 Outsourced Pharma Newsletter

16. 06.05.25 -- Outsourcing GLP-1 Programs: Is There Capacity For Biotechs? 6/5/2025
    06/05/25 Outsourced Pharma Newsletter
17. 06.04.25 -- Finding The Right CDMO Partner For Your Cell & Gene Therapy 6/4/2025
    06/04/25 Outsourced Pharma Newsletter
18. 06.04.25 -- Are Your Combination Products Ready For Tomorrow's Regulations? 6/4/2025

    06/04/25 Outsourced Pharma Newsletter

19. 06.04.25 -- Tariffs On Toys … And API? Biopharma As The Next Battleground 6/4/2025
    06/04/25 Outsourced Pharma Newsletter
20. 06.03.25 -- Unlock Higher Drug Loads With Nanoformed API Technology 6/3/2025

    06/03/25 Outsourced Pharma Newsletter